Semi-Annual Report — FY2026 H1
What FINDEX Inc. reported for the period from 2026-01-01 to 2026-12-31.
Filed 2026-08-13View the original on EDINET
How much it says
48Typical
What moved here
18named for the first time
Its own wording
30terms
Which filing this is
36/ 36newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
During the interim consolidated accounting period (1 January 2026 to 30 June 2026), net sales were ¥3,145 million and operating income was ¥888 million, while interim net income attributable to owners of the parent was ¥560 million. Upfront investment in the healthcare technology business and the recognition of a valuation loss on investment securities affected profit, and the full-year forecasts remain unchanged.
Komori's summary of this document, not the document's own words.48Typical
How much this filing saysA weighted roll-up of 10 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 35 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
73
Detailed
61
Detailed
54
Typical
75
Very detailed
35
Thin
12
Almost nothing
0
Almost nothing
13
Almost nothing
79
Very detailed
73
Detailed
R&D spend22百万円Money spent making new things.
Cash left over11億円Cash from the business, less what went into equipment.
Spent on equipment2億円Plants, machines — things meant to last.
EmployeesNot disclosedThis document does not carry the figure.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.